Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-12
2005-07-12
Trinh, Ba K. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S469000, C514S469000
Reexamination Certificate
active
06916941
ABSTRACT:
Crystalline particles of escitalopram oxalate with a particle size of at least 40 μm is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
REFERENCES:
patent: 3467675 (1969-09-01), Petersen et al.
patent: 4136193 (1979-01-01), Bogeso et al.
patent: 4650884 (1987-03-01), Bogeso
patent: 4721723 (1988-01-01), Barnes et al.
patent: 4943590 (1990-07-01), Boegesoe et al.
patent: 5296507 (1994-03-01), Tanaka et al.
patent: 5683720 (1997-11-01), Myers et al.
patent: 5840334 (1998-11-01), Raiden et al.
patent: 5869098 (1999-02-01), Misra et al.
patent: 5980941 (1999-11-01), Raiden et al.
patent: 2001/0049450 (2001-12-01), Ikemoto et al.
patent: 2178637 (1995-06-01), None
patent: 2163840 (1996-05-01), None
patent: 2291067 (1998-05-01), None
patent: 2291072 (1998-05-01), None
patent: 2291129 (1999-06-01), None
patent: 2291134 (2000-04-01), None
patent: 0 171 943 (1988-11-01), None
patent: 0 347 066 (1989-12-01), None
patent: 0 714 663 (1996-06-01), None
patent: 07140663 (1997-01-01), None
patent: 1 152 000 (2001-11-01), None
patent: 1358915 (1974-07-01), None
patent: 2357762 (2001-07-01), None
patent: WO-99/03469 (1999-01-01), None
patent: WO 00/11926 (2000-03-01), None
patent: WO 01/22941 (2001-04-01), None
patent: WO-01/68627 (2001-09-01), None
International Search Report for PCT/DK02/00513, 2002.
Kirk-Othmer,Encyclopedia of Chemical Technology,Second Edition, vol. 6:482, New York, John Wiley & Sons, 1965.
Kunsemuller, Johannes, Ed.,Meyers Lexikon der Technik und der exakten Naturwissenschaften: 1151, Mannheim/Wien/Zurich: Bibliographisches Institute (1970).
Bates, Robert B., et al., Ed.Research Techniques in Organic Chemistry:50-52, Englewood Cliffs, NJ: Prentice Hall, Inc. (1971).
Organikum: Organisch-Chemisches Grundpraktikum:pp. 39-41, Veb Deutscher Verlag Der Wissenschaften, Berlin (1974).
Hyttel, John, “Citalopram—Pharmacological Profile of a Specific Serotonin Uptake Inhibitor with Antidepressant Activity, ”Prog. Neuro-Psychopharmacol&Biol. Psychiat.6: 277-295 (1982).
Gravem, A., et al. “A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients,” Acta Psychiatr. Scand. 75: 478-486 (1987).
Furniss, Brian, Ed.,Vogel's Textbook of Practical Organic Chemistry,Fifth Edition: 135-6, New York: Longman Scientific & Technical (john Wiley & Sons, Inc.) (1989).
Numberg, E., et al., Ed.,Hagers Handbuch der pharmazeutishen Praxis,vol. 5: 549-51, Springer-Verlag: Wissenschaftlicher Beirat (1991).
Kirk-Othmer,Encyclopedia of Chemical Technology,Fourth Edition, vol. 7: 683-5, New York: John Wiley & Sons (1993).
Webpage from Lundbeck website (www.lundbeck.com), company's activities Sep. 26, 2003.
Webpage from Lundbeck website (www.lundbeck.com): Product information on Cipramll Sep. 26, 2003.
Remington's Pharmaceutical Sciences, 18th Edition, Chapter 89, Oral Solid Dosage Forms pp. 1633-1658, 1990.
Bhogi B. Sheth, et al., Compressed Tablets, Chapter 3 in Pharmaceutical Dosage Forms: Tablets, vol. 1, H. Lieberman and L. Lachman eds., Marcel Dekker, Inc., New York and Basel, 1979, pp. 109-185.
Chapters 2 to 4 in Pharmaceutical Dosage Forms: Tablets, vol. 1, H. Lieberman and L. Lachman, eds., Marcel Dekker, Inc. New York and Basel 1989, pp. 75-246 (Chapter 2: Tablet and Formulation Design; Chapter 3: Compressed Tablets by Wet Granulation; Chapter 4: Compressed Tablets by Direct Compression).
Keith Marshall, Compression and Consolidation of Powdered Solids, Chapter 4, The Theory and Practise of Industrial Pharmacy, Lieberman, Lachman, and Kanig, eds., 3rd Edition, 1986, pp. 66-99.
Hoener et al., Chapter 4, Factors Influencing Drug Absorption and Drug Availability, Modern Pharmaceutics, 3rd edition, Banker and Rhodes, eds., Marcel Dekker, New York and Basel, 1995, pp. 121-153.
Edward M. Rudnic, et al., Chapter 10, Tablet Dosage Forms, Modern Pharmaceutics, 3d edition, Banker and Rhodes, eds., Marcel dekker, New York and Basel, 1995, pp. 333-394.
Joseph B. Schwartz, et al., Chapter 18, Optimazation Techniques in Pharmaceutical Formulation and Processing, Modern Pharmaceutics, 3rd Edition, Banker and Rhodes, eds., Marcel Dekker, New York and Basel, 1995, pp. 727-752.
Gunsel, et al, Chapter 11, Tablets, The Theory and Practice of Industrial Pharmacy Lieberman, Lachman, and Kanig, eds., 2nd edition, 1976,pp. 321-358.
Keith Marshall, Chapter 10, Solid Oral Disage Forms, Modern Pharmaceutics, 1st Edition, Banker and Rhodes, eds., Marcel Dekker, New York and Basel, 1979, p. 359-427.
Vogel's Textbook of Practical Organic Chemistry, Fourth Edition, pp. 100-263, 1978.
Dr. Fritz Gstimer, Professor fur Pharmazeutische Technologie an der Universitat Bonn, 1973, Einfuhrung in Die Verfahrenstechnik Der Arzneiformung, pp. 201-203 (and English Translation).
O'Connor, R.E. et al., Chapter 91 Powders, Remington: The Science and Practise of Pharmacy, 19th Ed., A. Gennaro, editor, Mack Publishing Co., Easton, 1995, pp. 1598-1613.
Banker, G.S., et al., Chapter 11, Tablets, The Theory and Practice of Industrial Pharmacy, Lieberman, Lachman, and Kanig, eds, 3rd Edition, 1988, pp. 293-345.
Hoener et al., Chapter 4, Factors Influencing Drug Absorption and Drug Availability, Modern Pharmaceutics, 1st edition, Banker and Rhodes, eds., Marcel Dekker, New York and Basel, 1979, pp. 143-182.
Joseph B. Schwartz, et al., Chapter 17, Optimization Techniques in Pharmaceutical Formulation and Processing, Modern Pharmaceutics, 1st Edition, Banker and Rhodes, eds., Marcel Dekker, New York and Basel, 1979, pp. 711-734.
N. Hirayama “Crystallization by control of temperature change,” from “Handbook for Preparing Organic Crystals,” SECTION 3/1/1, pp. 34-35 (Apr. 20, 2000) (and English language translation).
Pierre Carre, “Dissolution dans les Liquides,” Precis de Technologie et de Chimie Industrielle: 319-320, Librairie J.-B. Bailliere et Fils (1938) (and English language translation).
Andresen Lene
Assenza Sebastian P.
Christensen Troels Volsgaard
Elema Michiel Onne
Liljegren Ken
Darby & Darby
H. Lundbeck A/S
Trinh Ba K.
LandOfFree
Crystalline composition containing escitalopram does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline composition containing escitalopram, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline composition containing escitalopram will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3411231